Sangrix Inc. (SGRX) Income Statement
SGRX FY2026 at a glance
Fiscal year ended June 30, 2026 · U.S. dollarsSGRX revenue and net income
SGRX profit margins
SGRX growth rates
to FY2026| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −100.0% | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
SGRX income statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $39,495 | $2.9M | $6.3M | $192,351 | $0 | $24.2M | $99.1M | $101.1M | $63.3M |
| Cost of revenue | $0 | — | $3.8M | $10.8M | $403,384 | — | $22.2M | $90.4M | $91.5M | $58.2M |
| Gross profit | $0 | — | −$945,202 | −$4.6M | −$211,033 | — | $2.0M | $8.7M | $9.7M | $5.1M |
| Sales, general & admin | $2.8M | — | $3.9M | $3.0M | $5.8M | — | — | — | — | — |
| Total operating expenses | $3.4M | $3.0M | $13.9M | $23.7M | $5.8M | $3.5M | $4.6M | $2.6M | $4.1M | $1.5M |
| Operating income | −$3.4M | −$3.0M | −$14.8M | −$28.3M | −$6.1M | −$3.5M | −$2.6M | $6.1M | $5.5M | $3.5M |
| Interest income | $210,000 | $210,000 | $97,917 | — | — | — | — | — | — | — |
| Interest expense | $0 | $455,194 | $497,768 | $227,376 | $54,137 | $156,048 | $529,510 | $849,174 | $1.3M | $667,748 |
| Income before taxes | −$14.3M | −$4.4M | −$18.3M | −$28.2M | −$5.3M | −$3.6M | −$3.1M | $5.2M | $4.5M | $3.3M |
| Income taxes | — | — | — | — | — | — | $223,173 | $213,649 | $714,376 | $875,737 |
| Net income | −$14.3M | −$4.4M | −$17.5M | −$28.2M | $3.2M | −$45.6M | −$4.9M | $4.4M | $3.8M | $2.5M |
| EBITDA | −$14.3M | −$3.0M | −$16.9M | −$22.6M | −$5.8M | −$3.5M | −$2.6M | $6.6M | $6.1M | $4.1M |
| EPS (diluted) | −$19.12 | −$14.73 | −$619.49 | −$2391.22 | $297.19 | — | — | — | — | — |
| Gross margin | — | — | −32.7% | −72.9% | −109.7% | — | 8.4% | 8.7% | 9.5% | 8.0% |
| Operating margin | — | −7,574.9% | −513.6% | −452.1% | −3,149.6% | — | −10.8% | 6.1% | 5.5% | 5.6% |
| Net margin | — | −11,108.2% | −607.0% | −450.7% | 1,684.1% | — | −20.1% | 4.4% | 3.7% | 3.9% |
| Mar '26 | Sep '25 | Mar '25 | Sep '24 | Dec '23 | Sep '23 | Dec '22 | Dec '21 | Dec '20 | Mar '20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $39,495 | $0 | $0 | $2.9M | $4.2M | $2.1M | $0 | $62.4M | $50.0M |
| Cost of revenue | — | — | — | — | $3.8M | $6.6M | $4.2M | — | $59.4M | $46.1M |
| Gross profit | — | — | — | — | −$945,202 | −$2.4M | −$2.2M | — | $3.0M | $4.0M |
| Total operating expenses | $1.0M | $1.1M | $1.9M | $3.7M | $1.3M | $4.6M | $1.7M | $1.7M | $3.8M | $3.5M |
| Operating income | −$1.0M | −$1.1M | −$1.9M | −$3.7M | −$2.2M | −$7.0M | −$3.9M | −$1.7M | −$782,051 | $487,292 |
| Interest expense | $508,505 | $17,870 | $473,064 | $98,809 | $398,959 | $99,773 | $127,603 | $33,394 | $340,548 | $478,344 |
| Income before taxes | −$8.6M | −$1.6M | −$2.8M | −$11.2M | −$7.1M | −$24.2M | −$4.0M | −$917,292 | −$1.1M | −$77,601 |
| Income taxes | — | — | — | — | — | — | — | — | $117,363 | — |
| Net income | −$8.7M | −$1.6M | −$2.8M | −$10.5M | −$7.1M | −$24.2M | −$4.0M | −$23.8M | −$9.6M | −$617,052 |
| EBITDA | −$1.0M | −$1.1M | −$1.9M | −$3.7M | −$1.3M | −$4.0M | −$1.5M | −$1.7M | −$778,770 | $808,078 |
| Gross margin | — | — | — | — | −32.7% | −56.9% | −105.6% | — | 4.8% | 8.0% |
| Operating margin | — | −2,747.5% | — | — | −76.9% | −165.8% | −187.2% | — | −1.3% | 1.0% |
| Net margin | — | −4,005.2% | — | — | −244.4% | −576.4% | −194.3% | — | −15.4% | −1.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in SGRX's financial statements (latest annual report filed —); data from EODHD. Sales, general & administrative expenses include sales and marketing.
SGRX financial results
Sangrix reported no revenue in fiscal year 2026 (ended June 30, 2026). It had a net loss of $14.3 million. Diluted earnings per share came to −$19.12.
See the SGRX stock overview for the latest quote and news, or the SGRX chart for price history and technical indicators.
SGRX income statement FAQ
Does Sangrix have revenue?
Sangrix reported no revenue for fiscal year 2026, which ended on June 30, 2026.
Is Sangrix profitable?
No. Sangrix reported a net loss of $14.3 million in fiscal 2026.
What are Sangrix's earnings per share?
Sangrix earned $-19.12 per diluted share in fiscal 2026, compared with $-14.73 a year earlier.
When will Sangrix report its next earnings?
Sangrix is expected to report results for the quarter ending September 30, 2026 on October 30, 2026.
When does Sangrix's fiscal year end?
Sangrix's fiscal year ends in June. The latest annual report covers the year ended June 30, 2026.